Background/Aim: Although few studies have shown the effectiveness of adjuvant therapy
with acridine orange (AO) for soft tissue sarcoma (STS) patients, no study has investigated …

Background/Aim: Local recurrence in soft tissue sarcoma (STS) is a risk factor of worse
prognosis. Although a few studies have shown that adjuvant therapy with acridine orange …

Background We investigated the long-term clinical efficacy of acridine orange (AO) therapy
on the inhibition of local recurrence after marginal or intra-lesional tumor resection in high …

Although limb salvage surgery involving wide resection and limb reconstruction for
musculoskeletal sarcomas is well established for low risk of local tumor recurrence, limb …

Background To maintain excellent limb function after tumor resection in patients with high‐
grade malignant sarcomas, we developed and established a new surgical adjuvant therapy …

The objective of this study is to assess the effect of anthracyclines/ifosfamide-based adjuvant
chemotherapy for soft tissue sarcoma (STS) and provide a relative ranking of regimens for …

10042 Background: A growing body of literature suggests that adjuvant anthracycline
chemotherapy combination may have potential to improve survival in patients with soft tissue …

Background Wide-margin resections are an accepted method for treating soft tissue
sarcoma. However, a wide-margin resection sometimes impairs function because of the lack …

Introduction: This retrospective study analyzes the safety and feasibility of concurrent
chemoradiotherapy (CRT) in adjuvant treatment of soft tissue sarcoma (STS). Methods: A …

Purpose The role of adjuvant chemotherapy (ACT) for soft tissue sarcomas (STS) is not
standard practice. We investigated effectiveness and tolerability of ACT in patients (pts) with …